JP Morgan Chase’s Revolution Medicines RVMD Stock Holding History

JP Morgan Chase’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40.8M	Buy	+211,800	New	+$30.9M	﹤0.01%	1623

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

JP Morgan Chase's RVMD Position: Q2 2026 in Review

JP Morgan Chase increased its Revolution Medicines (RVMD) stake by 994% in Q2 2026, buying an estimated $438M and bringing the position to 3,298,066 shares worth $637M. The position accounts for 0.04% of the portfolio, ranked #392.

JP Morgan Chase first reported a position in RVMD in Q1 2020 and has held it in 26 quarters since. 689 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

JP Morgan Chase held 3,298,066 shares of Revolution Medicines worth $637M as of Q2 2026.
JP Morgan Chase bought 2,996,673 Revolution Medicines shares in Q2 2026, an estimated $438M.
Revolution Medicines made up 0.04% of JP Morgan Chase's portfolio in Q2 2026, its #392 holding.
JP Morgan Chase first reported a position in Revolution Medicines in Q1 2020 and has held it in 26 quarters since.
689 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.